Abstract

The experience with magnetic resonance imaging (MRI) used to diagnose prostate cancer (PC) is more than 35 years. Cardinal changes have occurred over that time. The accumulation of experience and the development of technologies have given rise to multiparameter MRI (mpMRI) involving the assessment of both functional and anatomic images. The International MRI Working Group on PC Diagnosis was set up in 2007. The Group has elaborated the basic principles of the standardization and compatibility of MRI studies, which are embodied in the European Society of Urogenital Radiology (ESUR) guidelines as a PI-RADS. The development of this system could create conditions for reducing variations in MRI procedures, interpretation, and mpMRI report forms for PC. The system has realized a scale of rating categories that summarize levels of suspicion or risk and that may be used to select patients for different tactics, such as biopsy or active monitoring. Furthermore, such an optimized approach allows reproducible MRI studies for monitoring during an active follow-up and for the early detection of recurrences. Therefore, PI-RADS enables one to systematize MRI reports and to unify the language of communication between radiologists, urologists, and oncologists. Owing to the rapid widespread and introduction of the PI-RADS system, it has become possible to analyze its efficiency and to reveal some critical moments. The pooling of the resources of the American College of Radiology (ACR), (ESUR), and the AdMetech Foundation has permitted an Ad Hoc Coordinating Committee, the activity of which is to obtain scientific evidence and to form expert opinions to improve the system, as a result of which an updated PI-RADSv2 was published in 2015. This paper deals with the basic principles of a prostate MRI analysis in accordance with the PI-RADSv2 grades.

Highlights

  • A system of a unified approach to interpreting prostate magnetic resonance imaging according to the PI-RADSv2 guidelines

  • The Group has elaborated the basic principles of the standardization and compatibility of magnetic resonance imaging (MRI) studies, which are embodied in the European Society of Urogenital Radiology (ESUR) guidelines as a PI-RADS

  • This paper deals with the basic principles of a prostate MRI analysis in accordance with the PI-RADSv2 grades

Read more

Summary

TZp TZp PZpl PZpm PZpm PZpl

В системе PIRADSv2 процесс выявления клинически значимого рака предполагает стандартизацию отчета мпМРТ и корреляцию с патологическими изменениями для клинических и исследовательских задач. Для PIRADSv2 клинически значимый РПЖ определяется при патоморфологическом (гистологическом) исследовании как участок с суммой баллов по шкале Гли-. При интерпретации данных Т2-ВИ градации PIRADSv2 определяются на основе специфических МРпризнаков 3, очаги клинически значимого рака в периферической зоне определяются в виде отграниченных очагов выраженно сниженного сигнала интенсивности, размерами > 1,5 см и признаками инвазивного роста [18, 19]. Для клинически значимого рака центральных отделов ПЖ характерно специфическое изменение структуры МР-сигнала по типу «растертого угля», при размерах очагов более 1,5 см, с признаками интра- и экстракапсулярного инвазивного роста [20, 21]. Анализ осуществляется на основании ДВИ с высоким фактором диффузии (>800 с/мм2) и параметрической карты измеряемого коэффициента диффузии (ИКД) (табл. 4) [22, 23]

Определение рисков наличия клинически значимого РПЖ
Характеристика изменений паренхимы периферической и транзиторной зон
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call